The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs von van der Velden, D. L., Hoes, L. R., van der Wijngaart, H., van Berge Henegouwen, J. M., van Werkhoven, E., Roepman, P., Schilsky, R. L., de Leng, W. W. J., Huitema, A. D. R., Nuijen, B., Nederlof, P. M., van Herpen, C. M. L., de Groot, D. J. A., Devriese, L. A., Hoeben, A., de Jonge, M. J. A., Chalabi, M., Smit, E. F., de Langen, A. J., Mehra, N., Labots, M., Kapiteijn, E., Sleijfer, S., Cuppen, E., Verheul, H. M. W., Gelderblom, H., Voest, E. E.

Volltext

Development and validation of a liquid chromatography–tandem mass spectrometry analytical method for the therapeutic drug monitoring of eight novel anticancer drugs von Herbrink, M., Vries, N., Rosing, H., Huitema, A. D. R., Nuijen, B., Schellens, J. H. M., Beijnen, J. H.

Volltext

Inventory of oral anticancer agents: pharmaceutical formulation aspects with focus on the solid dispersion technique von Sawicki, E, Schellens, J.H.M, Beijnen, J.H, Nuijen, B

Volltext

Parents’ experiences with a home-based upper limb training program using a video coaching approach for infants and toddlers with unilateral cerebral palsy: a qualitative interview... von Verhaegh, Anke PM, Nuijen, Nienke B, Aarts, Pauline BM, Nijhuis-van der Sanden, Maria W G, Willemsen, Michèl AAP, Groen, Brenda E, Vriezekolk, Johanna E

Volltext

Stability of oxaliplatin in chloride-containing carrier solutions used in hyperthermic intraperitoneal chemotherapy von Mehta, A.M., Van den Hoven, J.M., Rosing, H., Hillebrand, M.J.X., Nuijen, B., Huitema, A.D.R., Beijnen, J.H., Verwaal, V.J.

Volltext

Inherent formulation issues of kinase inhibitors von Herbrink, M., Schellens, J.H.M., Beijnen, J.H., Nuijen, B.

Volltext

Pharmaceutical development and preliminary clinical testing of an oral solid dispersion formulation of docetaxel (ModraDoc001) von Moes, J.J., Koolen, S.L.W., Huitema, A.D.R., Schellens, J.H.M., Beijnen, J.H., Nuijen, B.

Volltext

Basics of advanced therapy medicinal product development in academic pharma and the role of a GMP simulation unit von Johanna, I., Daudeij, A., Devina, F., Nijenhuis, C., Nuijen, B., Romberg, B., de Haar, C., Haanen, J., Dolstra, H., Bremer, E., Sebestyen, Z., Straetemans, T., Jedema, I., Kuball, J.

Volltext

Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies von Sawicki, E., Schellens, J. H. M., Beijnen, J. H., Nuijen, B.

Volltext

Phase I pharmacological study of continuous chronomodulated capecitabine treatment von Roosendaal, J., Jacobs, B.A.W., Pluim, D., Rosing, H., Nuijen, B., Beijnen, J.H., Huitema, A.D.R., Schellens, J.H.M., Marchetti, S.

Volltext

Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of Dexamphetamine in human plasma von Herbrink, M., Thijssen, B., Hillebrand, M.J.X., Rosing, H., Schellens, J.H.M., Nuijen, B., Beijnen, J.H.

Volltext

Randomized phase III study comparing a non-myeloablative lymphocyte depleting regimen of chemotherapy followed by infusion of tumor infiltrating lymphocytes and interleukine-2 to s... von Rohaan, M.W., Borch, T.H., van den Berg, J.H., Geukes Foppen, M.H., Donia, M., Met, Ö, Nuijen, B., van Zon, M., Bakker, E.A.M., de Boer, R., Pronk, L.M., Wilgenhof, S., Blank, C.U., van Thienen, J.V., van Akkooi, A.C.J., Svane, I.-M., Haanen, J.B.A.G.

Volltext

Transposon leads to contamination of clinical pDNA vaccine von van der Heijden, I, Gomez-Eerland, R, van den Berg, J.H, Oosterhuis, K, Schumacher, T.N, Haanen, J.B.A.G, Beijnen, J.H, Nuijen, B

Volltext

Development and validation of an anion-exchange LC-UV method for the quantification and purity determination of the DNA plasmid pDERMATT von Quaak, S.G.L., Nuijen, B., Haanen, J.B.A.G., Beijnen, J.H.

Volltext

GMP production of pDERMATT for vaccination against melanoma in a phase I clinical trial von Quaak, S.G.L., van den Berg, J.H., Toebes, M., Schumacher, T.N.M., Haanen, J.B.A.G., Beijnen, J.H., Nuijen, B.

Volltext

DNA tattoo vaccination: Effect on plasmid purity and transfection efficiency of different topoisoforms von Quaak, S.G.L., den Berg, J.H. van, Oosterhuis, K., Beijnen, J.H., Haanen, J.B.A.G., Nuijen, B.

Volltext

A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer von VELTKAMP, S. A, THIJSSEN, B, SCHELLENS, J. H. M, GARRIGUE, J. S, LAMBERT, G, LALLEMAND, F, BINLICH, F, HUITEMA, A. D. R, NUIJEN, B, NOL, A, BEIJNEN, J. H

Volltext

829P A proof of concept study of sequential treatment with the HDAC inhibitor vorinostat plus BRAF and MEK inhibitors in BRAFV600 mutated melanoma von Embaby, A., Huijberts, S.C.F.A., Wang, L., Leite de Oliveira, R., Rosing, H., Nuijen, B., Blank, C.U., van Thienen, H.V., Meerveld-Eggink, A., Haanen, J.B.A.G., Beijnen, J.H., Huitema, A., Bernards, R., Schellens, J.H.M., Wilgenhof, S.

Volltext

3PC-006 Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags von Van Den Berg, R, Akgöl, K, Swart, E, Nuijen, B, Crul, M

Volltext

LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial von Haanen, J.B.A.G., Rohaan, M., Borch, T.H., van den Berg, J.H., Met, Ö., Foppen, M. Geukes, Granhøj, J. Stoltenborg, Nuijen, B., Nijenhuis, C., Beijnen, J.H., Jedema, I., van Zon, M., Noringriis, I. Mansfield, Kessels, R., Wilgenhof, S., van Thienen, H.V., Lalezari, F., van Akkooi, A.C.J., Donia, M., Svane, I-M.

Volltext